AAAAAA

   
Results: 1-10 |
Results: 10
Blood vessel maturation in a 3-dimensional spheroidal coculture model: direct contact with smooth muscle cells regulates endothelial cell quiescence and abrogates VEGF responsiveness
Authors: Korff, T Kimmina, S Martiny-Baron, G Augustin, HG
Citation: T. Korff et al., Blood vessel maturation in a 3-dimensional spheroidal coculture model: direct contact with smooth muscle cells regulates endothelial cell quiescence and abrogates VEGF responsiveness, FASEB J, 15(2), 2001, pp. 447-457
Active interaction of human A375 melanoma cells with the lymphatics in vivo
Authors: Papoutsi, M Siemeister, G Weindel, K Tomarev, SI Kurz, H Schachtele, C Martiny-Baron, G Christ, B Marme, D Wilting, J
Citation: M. Papoutsi et al., Active interaction of human A375 melanoma cells with the lymphatics in vivo, HISTOCHEM C, 114(5), 2000, pp. 373-385
New anilinophthalazines as potent and orally well absorbed inhibitors of the VEGF receptor tyrosine kinases useful as antagonists of tumor-driven angiogenesis (vol 43, pg 2316, 2000)
Authors: Bold, G Altmann, KH Frei, J Lang, M Manley, PW Traxler, P Wietfeld, B Bruggen, J Buchdunger, E Cozens, R Ferrari, S Furet, P Hofmann, F Martiny-Baron, G Mestan, J Rosel, J Sills, M Stover, D Acemoglu, F Boss, E Emmenegger, R Lasser, L Masso, E Roth, R Schlachter, C Vetterli, W Wyss, D Wood, JM
Citation: G. Bold et al., New anilinophthalazines as potent and orally well absorbed inhibitors of the VEGF receptor tyrosine kinases useful as antagonists of tumor-driven angiogenesis (vol 43, pg 2316, 2000), J MED CHEM, 43(16), 2000, pp. 3200-3200
New anilinophthalazines as potent and orally well absorbed inhibitors of the VEGF receptor tyrosine kinases useful as antagonists of tumor-driven angiogenesis
Authors: Bold, G Altmann, KH Frei, J Lang, M Manley, PW Traxler, P Wietfeld, B Bruggen, J Buchdunger, E Cozens, R Ferrari, S Furet, P Hofmann, F Martiny-Baron, G Mestan, J Rosel, J Sills, M Stover, D Acemoglu, F Boss, E Emmenegger, R Lasser, L Masso, E Roth, R Schlachter, C Vetterli, W Wyss, D Wood, JM
Citation: G. Bold et al., New anilinophthalazines as potent and orally well absorbed inhibitors of the VEGF receptor tyrosine kinases useful as antagonists of tumor-driven angiogenesis, J MED CHEM, 43(12), 2000, pp. 2310-2323
PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration
Authors: Wood, JM Bold, G Buchdunger, E Cozens, R Ferrari, S Frei, J Hofmann, F Mestan, J Mett, H O'Reilly, T Persohn, E Rosel, J Schnell, C Stover, D Theuer, A Towbin, H Wenger, F Woods-Cook, K Menrad, A Siemeister, G Schirner, M Thierauch, KH Schneider, MR Drevs, J Martiny-Baron, G Totzke, F Marme, D
Citation: Jm. Wood et al., PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration, CANCER RES, 60(8), 2000, pp. 2178-2189
Effects of PTK787/ZK 222584, a specific inhibitor of vascular endothelial growth factor receptor tyrosine kinases, on primary tumor, metastasis, vessel density, and flood flow in a murine renal cell carcinoma model
Authors: Drevs, J Hofmann, I Hugenschmidt, H Wittig, C Madjar, H Muller, M Wood, J Martiny-Baron, G Unger, C Marme, D
Citation: J. Drevs et al., Effects of PTK787/ZK 222584, a specific inhibitor of vascular endothelial growth factor receptor tyrosine kinases, on primary tumor, metastasis, vessel density, and flood flow in a murine renal cell carcinoma model, CANCER RES, 60(17), 2000, pp. 4819-4824
Donor stromal cells from human blood engraft in NOD/SCID mice
Authors: Goan, SR Junghahn, I Wissler, M Becker, M Aumann, J Just, U Martiny-Baron, G Fichtner, I Henschler, R
Citation: Sr. Goan et al., Donor stromal cells from human blood engraft in NOD/SCID mice, BLOOD, 96(12), 2000, pp. 3971-3978
Targeting of endothelial KDR receptors with 3G2 immunoliposomes in vitro
Authors: Benzinger, P Martiny-Baron, G Reusch, P Siemeister, G Kley, JT Marme, D Unger, C Massing, U
Citation: P. Benzinger et al., Targeting of endothelial KDR receptors with 3G2 immunoliposomes in vitro, BBA-BIOMEMB, 1466(1-2), 2000, pp. 71-78
Inhibition of VEGF receptor tyrosine kinase
Authors: Siemeister, G Menrad, A Schirner, M Thierauch, KH Schneider, MR Martiny-Baron, G Marme, D Bold, G Rosel, J Wood, JM
Citation: G. Siemeister et al., Inhibition of VEGF receptor tyrosine kinase, ANGIOGENESIS IN HEALTH AND DISEASE, 2000, pp. 339-348
Two independent mechanisms essential for tumor angiogenesis: Inhibition ofhuman melanoma xenograft growth by interfering with either the vascular endothelial growth factor receptor pathway or the Tie-2 pathway
Authors: Siemeister, G Schirner, M Weindel, K Reusch, P Menrad, A Marme, D Martiny-Baron, G
Citation: G. Siemeister et al., Two independent mechanisms essential for tumor angiogenesis: Inhibition ofhuman melanoma xenograft growth by interfering with either the vascular endothelial growth factor receptor pathway or the Tie-2 pathway, CANCER RES, 59(13), 1999, pp. 3185-3191
Risultati: 1-10 |